ConcertAI’s TeraRecon adds AI-based oncology countering capabilities

ConcertAI’s TeraRecon adds AI-based oncology countering capabilities

ConcertAI’s TeraRecon adds AI-based oncology countering capabilities

ConcertAI’s TeraRecon Eureka clinical AI platform now provides clinicians with the cutting-edge artificial intelligence and deep learning technology required to automatically detect and segment pulmonary nodules and calculate coronary artery calcification through Coreline Soft solutions.

Coreline Soft offers artificial intelligence algorithms for use in medical imaging and specializes in imaging of the heart and lungs. Their AVIEW CAC algorithm was developed for thoracic and cardiac calcium assessment and can be used to automatically segment the heart and surrounding structures and accurately analyze calcified plaques in coronary arteries. Their AVIEW LCS+ algorithm is designed for breast cancer screening and can be used to detect lung nodules, measure emphysema index and calculate CAC on ungated scans. Both algorithms are designed for use with CT scans.

“With the addition of Coreline’s calcium scoring technologies to Eureka Clinical AI, we can help clinicians automatically analyze and quantify the image data derived from a single chest computed tomography (CT) scan and provide information about lung cancer and heart vascular diseases while increasing accuracy and efficiency while supporting earlier diagnosis and treatment for patients,” said Dan McSweeney, President of TeraRecon.

“TeraRecon’s significant global install base represents a significant and immediate distribution opportunity for the unique analytical capabilities of Coreline Soft’s oncology and cardiac solutions. We are very excited to bring our solutions to the Eureka Clinical AI platform and to all healthcare providers who require these services. in an optimized form and the best ecosystem of its kind that TeraRecon offers,” said Jinkook Kim, CEO of Coreline Soft.

Eureka Clinical AI is the leading AI SaaS image interpretation and clinical decision augmentation solution from ConcertAI’s TeraRecon. As the industry’s most widely used platform, it is unique in that it is open to third-party AI algorithms and allows for consolidated management of all AI interpretation solutions with seamless PACS integration. Multidisciplinary care teams can see outcomes and receive mobile notifications to confirm AI findings, ensuring optimal and timely patient interventions, management, and coordinated care delivery.

Share:
Facebook
LinkedIn
Twitter
We are just a click away
COLEDA B2B is one of the fastest growing B2B firm

Mon-Fri

24 Hours

Services

Get In Touch

301A and 301B, Building Alpha 2, Giga space Condominium, Viman nagar, Pune, Maharashtra, India 411014